Came across this interesting talk from the Indo US Bridging RARE Summit 2025 on why access to rare disease clinical trials shouldn't depend on where a patient lives. It's a thoughtful discussion on expanding research opportunities to underserved regions and making innovation more accessible to the people who need it most.
Came across this interesting talk from the Indo US Bridging RARE Summit 2025 on why access to rare disease clinical trials shouldn't depend on where a patient lives. It's a thoughtful discussion on expanding research opportunities to underserved regions and making innovation more accessible to the people who need it most.
0 Comentários
0 Compartilhamentos
31 Visualizações
4
0 Anterior
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian